Navigating the landscape of terminal care and access to medications like Pentobarbital in New South Wales, the state, requires a careful grasp of the complex legal framework. Currently, Pentobarbital does not have a approved place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not commonly prescribed by clinical professionals.